Stanley Nwabudike, MD

Dr. Stanley Nwabudike is a board-certified hematologist and medical oncologist dedicated to providing compassionate, patient-centered care for individuals with cancer and blood disorders. His clinical interests include optimizing cancer treatment outcomes and supporting patients through diagnosis, therapy, and survivorship.

Dr. Nwabudike completed his fellowship in Hematology and Medical Oncology at Boston University/Boston Medical Center, where he led research on improving lung cancer screening follow-up and co-developed a model to predict cisplatin-related kidney injury. He completed his Internal Medicine residency at Howard University Hospital in Washington, D.C., where he served as Assistant Chief Resident, and trained in Ireland and Nigeria.

He is an active member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians and National Medical Association. His work has been published in peer-reviewed journals and presented at national scientific meetings.

Patients value his collaborative approach, clear communication, and dedication to delivering evidence-based, personalized treatment plans.